ID

36998

Beschreibung

Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02388932

Link

https://clinicaltrials.gov/show/NCT02388932

Stichworte

Versionen (1)
  1. 27.06.19 27.06.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

27. Juni 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Recurrent Hypopharyngeal Squamous Cell Carcinoma NCT02388932

Englisch

Eligibility Recurrent Hypopharyngeal Squamous Cell Carcinoma NCT02388932

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
the patient must have squamous cell carcinoma proven by histologic diagnosis; for cancers of the oropharynx, p16 staining by immunohistochemistry must be negative; for cancers of the larynx, hypopharynx, oral cavity, nasopharynx, paranasal sinuses, p16 staining is not required
Beschreibung

Squamous cell carcinoma | Oropharyngeal Carcinoma Immunohistochemistry Negative | P16 Staining Immunohistochemistry | Carcinoma of larynx | Hypopharyngeal Carcinoma | Oral Cavity Carcinoma | Nasopharyngeal carcinoma | Paranasal Sinus Cancer

Datentyp

boolean

Alias
UMLS CUI [1]
C0007137
UMLS CUI [2,1]
C2349952
UMLS CUI [2,2]
C0021044
UMLS CUI [2,3]
C1513916
UMLS CUI [3,1]
C2354136
UMLS CUI [3,2]
C0487602
UMLS CUI [3,3]
C0021044
UMLS CUI [4]
C0595989
UMLS CUI [5]
C1368404
UMLS CUI [6]
C0151546
UMLS CUI [7]
C2931822
UMLS CUI [8]
C0854995
the patient must have clinical stage t1-4, n0-3, m0-1, stage ii-ivc carcinoma as per the 7th edition of the american joint committee on cancer (ajcc) staging manual; patients with t1n0m0 or t2n0m0 will be ineligible; patients with metastatic disease with a limited metastatic burden are eligible if obtaining local control is determined by their treating oncologist to be an important therapeutic goal
Beschreibung

Carcinoma TNM clinical staging | Neoplasm Metastasis Burden Limited

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0007097
UMLS CUI [1,2]
C3258246
UMLS CUI [2,1]
C0027627
UMLS CUI [2,2]
C1449699
UMLS CUI [2,3]
C0439801
the patient must have imaging documenting a primary tumor, or involved lymph node, >= 2.5 cm in greatest dimension
Beschreibung

Primary tumor Longest Diameter Imaging | Lymph Node Involvement Longest Diameter Imaging

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0677930
UMLS CUI [1,2]
C0552406
UMLS CUI [1,3]
C0011923
UMLS CUI [2,1]
C0806692
UMLS CUI [2,2]
C0552406
UMLS CUI [2,3]
C0011923
pet/ct is required for all patients, unless contraindicated; this may be acquired prior to study entry or after enrollment prior to sbrt planning
Beschreibung

PET/CT Required | Exception Medical contraindication

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1699633
UMLS CUI [1,2]
C1514873
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C1301624
the patient must have a history and physical documented within four weeks of registration and be deemed by a medical oncologist to be ineligible for standard continuous course chemoradiotherapy with cisplatin
Beschreibung

Patient Ineligible Cisplatin Chemotherapy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1512714
UMLS CUI [1,3]
C0008838
UMLS CUI [1,4]
C0392920
karnofsky performance status (ps) >= 40
Beschreibung

Karnofsky Performance Status

Datentyp

boolean

Alias
UMLS CUI [1]
C0206065
female patients cannot be of childbearing age, or if they are, must have a negative pregnancy test prior to enrollment and be willing to use contraceptives during treatment and continue for 6 additional months
Beschreibung

Childbearing Potential Absent | Childbearing Potential Pregnancy test negative | Childbearing Potential Contraceptive methods

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0427780
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0700589
patients must have the ability to understand and the willingness to sign a written informed consent document
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with t1n0m0 stage i disease
Beschreibung

Disease TNM clinical staging

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C3258246
patients who are receiving any other investigational agents
Beschreibung

Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C0013230
patients with non-squamous cell histology
Beschreibung

Non-squamous cell Histology

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1545484
UMLS CUI [1,2]
C0344441
patients with life expectancy < 6 months
Beschreibung

Life Expectancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
patients who cannot lie flat for 20 minutes
Beschreibung

Lacking Able to maintain a lying position Duration

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0332268
UMLS CUI [1,2]
C4075030
UMLS CUI [1,3]
C0449238
patients with prior history of head and neck radiotherapy (> 40 gy) with significant areas of anticipated overlap
Beschreibung

Radiotherapy to head and neck

Datentyp

boolean

Alias
UMLS CUI [1]
C3888854
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Recurrent Hypopharyngeal Squamous Cell Carcinoma NCT02388932

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Squamous cell carcinoma | Oropharyngeal Carcinoma Immunohistochemistry Negative | P16 Staining Immunohistochemistry | Carcinoma of larynx | Hypopharyngeal Carcinoma | Oral Cavity Carcinoma | Nasopharyngeal carcinoma | Paranasal Sinus Cancer
Item
the patient must have squamous cell carcinoma proven by histologic diagnosis; for cancers of the oropharynx, p16 staining by immunohistochemistry must be negative; for cancers of the larynx, hypopharynx, oral cavity, nasopharynx, paranasal sinuses, p16 staining is not required
boolean
C0007137 (UMLS CUI [1])
C2349952 (UMLS CUI [2,1])
C0021044 (UMLS CUI [2,2])
C1513916 (UMLS CUI [2,3])
C2354136 (UMLS CUI [3,1])
C0487602 (UMLS CUI [3,2])
C0021044 (UMLS CUI [3,3])
C0595989 (UMLS CUI [4])
C1368404 (UMLS CUI [5])
C0151546 (UMLS CUI [6])
C2931822 (UMLS CUI [7])
C0854995 (UMLS CUI [8])
Carcinoma TNM clinical staging | Neoplasm Metastasis Burden Limited
Item
the patient must have clinical stage t1-4, n0-3, m0-1, stage ii-ivc carcinoma as per the 7th edition of the american joint committee on cancer (ajcc) staging manual; patients with t1n0m0 or t2n0m0 will be ineligible; patients with metastatic disease with a limited metastatic burden are eligible if obtaining local control is determined by their treating oncologist to be an important therapeutic goal
boolean
C0007097 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C0027627 (UMLS CUI [2,1])
C1449699 (UMLS CUI [2,2])
C0439801 (UMLS CUI [2,3])
Primary tumor Longest Diameter Imaging | Lymph Node Involvement Longest Diameter Imaging
Item
the patient must have imaging documenting a primary tumor, or involved lymph node, >= 2.5 cm in greatest dimension
boolean
C0677930 (UMLS CUI [1,1])
C0552406 (UMLS CUI [1,2])
C0011923 (UMLS CUI [1,3])
C0806692 (UMLS CUI [2,1])
C0552406 (UMLS CUI [2,2])
C0011923 (UMLS CUI [2,3])
PET/CT Required | Exception Medical contraindication
Item
pet/ct is required for all patients, unless contraindicated; this may be acquired prior to study entry or after enrollment prior to sbrt planning
boolean
C1699633 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C1301624 (UMLS CUI [2,2])
Patient Ineligible Cisplatin Chemotherapy
Item
the patient must have a history and physical documented within four weeks of registration and be deemed by a medical oncologist to be ineligible for standard continuous course chemoradiotherapy with cisplatin
boolean
C0030705 (UMLS CUI [1,1])
C1512714 (UMLS CUI [1,2])
C0008838 (UMLS CUI [1,3])
C0392920 (UMLS CUI [1,4])
Karnofsky Performance Status
Item
karnofsky performance status (ps) >= 40
boolean
C0206065 (UMLS CUI [1])
Childbearing Potential Absent | Childbearing Potential Pregnancy test negative | Childbearing Potential Contraceptive methods
Item
female patients cannot be of childbearing age, or if they are, must have a negative pregnancy test prior to enrollment and be willing to use contraceptives during treatment and continue for 6 additional months
boolean
C3831118 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0427780 (UMLS CUI [2,2])
C3831118 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
Informed Consent
Item
patients must have the ability to understand and the willingness to sign a written informed consent document
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Disease TNM clinical staging
Item
patients with t1n0m0 stage i disease
boolean
C0012634 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Investigational New Drugs
Item
patients who are receiving any other investigational agents
boolean
C0013230 (UMLS CUI [1])
Non-squamous cell Histology
Item
patients with non-squamous cell histology
boolean
C1545484 (UMLS CUI [1,1])
C0344441 (UMLS CUI [1,2])
Life Expectancy
Item
patients with life expectancy < 6 months
boolean
C0023671 (UMLS CUI [1])
Lacking Able to maintain a lying position Duration
Item
patients who cannot lie flat for 20 minutes
boolean
C0332268 (UMLS CUI [1,1])
C4075030 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
Radiotherapy to head and neck
Item
patients with prior history of head and neck radiotherapy (> 40 gy) with significant areas of anticipated overlap
boolean
C3888854 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video